PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
April 3, 2026Archives of Medical Research0 citationsOpen Access

Associations of Estrogen Receptor 1 and Vitamin D Receptor Gene Polymorphisms with Bone Resorption During Pregnancy and Early Postpartum in a Mexican Cohort

View Full Paper
CMClaudia Morales-GómezÁSÁngel SantiagoAEAdrienne S. Ettinger

Key Points

  • The study aims to examine how genetic variations in ESR1 and VDR influence bone resorption during pregnancy and early postpartum.
  • Analyzed data from 575 women in the ELEMENT cohort
  • Measured urinary N-telopeptide of type I collagen in each trimester and one month postpartum
  • Genotyped six SNPs in ESR1 and VDR genes
  • Used random-effects regression and generalized additive models for association estimates
  • The VDR rs731236 CC genotype is associated with a ≈ 24% reduction in bone resorption (NTx levels) during pregnancy
  • No significant effects found for other genotypes tested

Abstract

P regnancy induces significant changes in calcium metabolism and bone turnover. Genetic variation in estrogen ( ESR1 ) and vitamin D ( VDR ) receptors may modulate maternal skeletal adaptation, but evidence in pregnancy and the postpartum period is limited. To evaluate the association between single nucleotide polymorphisms (SNPs) in the ESR1 and VDR genes and maternal bone resorption during pregnancy and early postpartum in a Mexican cohort. We analyzed data from 575 women participating in the Early Life Exposures in Mexico to ENvironmental Toxicants (ELEMENT) cohort. Urinary N-telopeptide of type I collagen (NTx) was measured in each trimester and at one month postpartum to assess bone resorption. Six SNPs were genotyped ( ESR1 : rs9340799, rs2234693, and rs3798577; VDR : rs731236, rs1544410, and rs7975232) and associations were estimated using random-effects regression and generalized additive models, adjusting for age, primigravidity, hematocrit, calcium and energy intake, breastfeeding status, and pregnancy stage. The rs731236 CC genotype ( VDR , TaqI) was associated with a significantly lower NTx level (≈ 24% reduction; p = 0.005), indicating a protective effect. None of the other loci were found to have a significant effect on bone resorption. Genetic variation in VDR (rs731236) was associated with lower maternal bone resorption during pregnancy and early postpartum. This finding highlights the potential relevance of specific genetic markers in understanding individual susceptibility to pregnancy-related bone loss.

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Morales-Gómez et al. (2026) studied this question.

synapsesocial.com/papers/69cf5cd15a333a821460a600https://doi.org/10.1016/j.arcmed.2026.103424
Ask AI
Helpful
Bookmark
Share
View Full Paper

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Changes in Urinary Excretions of C-Telopeptide and Cross-Linked N-Telopeptide of Type I Collagen during Pregnancy and Puerperium.1997 · 30 citations
  2. 2Bone Turnover Markers in the Diagnosis and Monitoring of Metabolic Bone Disease2016 · 387 citations
  3. 3Vitamin D and Estrogen Receptor Polymorphisms and Bone Mineral Changes in Postpartum Women2000 · 16 citations
  4. 4ESR1 Gene Variants Are Predictive of Osteoporosis in Female Patients with Crohn’s Disease2019 · 27 citations
  5. 5Interpreting non-coding variation in complex disease genetics2012 · 536 citations